4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid has been researched along with Disease Models, Animal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bliden, KP; Covic, L; Fletcher, EK; Gurbel, PA; Huang, T; Kimmelstiel, CD; Koukos, G; Kuliopulos, A; Rade, JJ; Rana, R; Shearer, A; Turner, SE | 1 |
| Dobolyi, A; Lakatos, K; Merkely, B; Nagy, Z; Nardai, S; Skopál, J | 1 |
| Falo, MC; Fillmore, HL; Phillips, LL; Reeves, TM | 1 |
| Amaral, FA; Andrade, MV; Fagundes, CT; Ferreira, FL; Lisboa, RA; Souza, DG; Teixeira, MM; Trifilieff, A; Vieira, AT | 1 |
4 other study(ies) available for 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid and Disease Models, Animal
| Article | Year |
|---|---|
Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Aortic Diseases; Atherosclerosis; Biomarkers; Carotid Artery Diseases; Cell Line; Cell-Penetrating Peptides; Clinical Trials, Phase II as Topic; Coronary Artery Disease; Disease Models, Animal; Disease Progression; Female; Fibrinolytic Agents; Human Umbilical Vein Endothelial Cells; Humans; Hydroxamic Acids; Lipopeptides; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 13; Matrix Metalloproteinase Inhibitors; Mice, Inbred C57BL; Mice, Knockout, ApoE; Middle Aged; Multicenter Studies as Topic; Oligopeptides; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Receptor, PAR-1; Signal Transduction; Tumor Necrosis Factor-alpha; United States | 2018 |
Delayed Gelatinase Inhibition Induces Reticulon 4 Receptor Expression in the Peri-Infarct Cortex.
Topics: Animals; Brain Infarction; Cerebral Cortex; Disease Models, Animal; Enzyme Inhibitors; Gelatinases; Gene Expression Regulation; GPI-Linked Proteins; Hydroxamic Acids; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Matrix Metalloproteinases; Myelin Proteins; Nerve Tissue Proteins; Nogo Receptor 1; Oligopeptides; Rats; Receptors, Cell Surface; RNA, Messenger | 2016 |
Matrix metalloproteinase-3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury.
Topics: Adaptation, Physiological; Analysis of Variance; Animals; Brain Injuries; Disease Models, Animal; Dizocilpine Maleate; Entorhinal Cortex; Functional Laterality; Gene Expression; Gene Expression Regulation; Hydroxamic Acids; Immunohistochemistry; Male; Matrix Metalloproteinase 3; Maze Learning; Microscopy, Electron, Transmission; Neuronal Plasticity; Neuroprotective Agents; Oligopeptides; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Synapses | 2006 |
Effects of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in a model of intestinal reperfusion injury in mice.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Capillary Permeability; Chemokines; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Hydroxamic Acids; Interleukin-10; Intestinal Mucosa; Intestines; Lung; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Oligopeptides; Reperfusion Injury; Survival Rate; Tumor Necrosis Factor-alpha | 2007 |